MedTrace Logo

The Role of Inflammation in Ocular Tumours

NCT02909517 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2019-05-23

No results posted yet for this study

Summary

This prospective, non-therapeutic study will determine whether a novel imaging technique can identify presumptive tumour associated macrophages (TAMs) in patients with ocular tumours.

The investigators will evaluate 5 groups:

1. Choroidal nevus
2. Choroidal indeterminate melanocytic lesion
3. Choroidal melanoma
4. Suspected metastatic tumour (ie, primary tumour elsewhere)
5. Locally treated ocular tumours

Conditions

  • Ocular Melanoma

Interventions

OTHER

cSLO imaging

Sponsors & Collaborators

  • Unity Health Toronto

    lead OTHER

Principal Investigators

  • Shelley Boyd, MD · Unity Health Toronto

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2020-05-31
Completion
2020-05-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02909517 on ClinicalTrials.gov